Financial Year |
March 31 2023 |
Monetary Funds |
1,404,055,380.49 |
Held-for-trading Financial Assets |
485,353,358.98 |
Notes Receivable |
4,662,800.00 |
Accounts Receivable |
731,477,004.28 |
Advances to Suppliers |
175,923,116.78 |
Other Receivables |
1,146,474,635.85 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
91,436,859.03 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
320,446,510.50 |
Total Current Assets |
11,693,941,602.71 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
3,160,853.34 |
Long-term Equity Investment |
252,676,298.59 |
Investment Properties |
33,486,060.81 |
Fixed Assetes |
48,723,564.74 |
Under-construction Projects |
56,439,330.82 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
173,900,776.09 |
R&D expenses |
-- |
Goodwill |
161,569,512.43 |
Long-Term Deferred and Prepaid Expenses |
5,258,622.85 |
Deferred Income Tax Assets |
65,025,056.71 |
Other Non-Current Assets |
107,647,526.55 |
Sub-Total of Non-Current Assets |
1,160,649,757.83 |
Total Assets |
12,854,591,360.54 |
Short-Term Loans |
331,183,333.34 |
Trading Financial liabilities |
-- |
Notes Payable |
258,721,044.73 |
Accounts Payable |
4,902,872,271.86 |
Accounts Received In Advance |
1,517,883.05 |
Employee Compensation Payable |
35,967,854.44 |
Taxes Payable |
60,407,913.47 |
Interest Payable |
-- |
Dividend Payable |
578,359.32 |
Other payables |
2,146,218,476.37 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,100,735,067.37 |
Other Current Liabilities |
797,240,074.87 |
Sub-Total of Current Liabilities |
10,066,910,205.95 |
Long-term Loans |
741,900,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
34,835,732.47 |
Other Non-Current Liabilities |
10,970,870.65 |
Sub-Total of Non-Current Liabilities |
795,587,759.39 |
Total Liabilities |
10,862,497,965.34 |
Paid-In Capital(Or Share Stock) |
352,280,000.00 |
Capital Surplus |
901,163,512.28 |
Surplus Reserve |
17,585,255.00 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
494,092,781.49 |
Minority Stockholder's Interest |
220,515,221.85 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,771,578,173.35 |
Owner's Equity(Stockholder's Equity) |
1,992,093,395.20 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
12,854,591,360.54 |